Replies to post #128984 on Biotech Values

[oc631]

What, exactly, do you take issue with? I can assure you that Feuerstein did not concoct the story that VRUS might have to pay IDIX a nuke-IP royalty—I heard the same thing from a portfolio manager some time ago. I don’t think this story has any substance (as I already noted), but it is out there.

A story without substance is a rumor. What IP was infringed?